Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.600
+0.060 (3.90%)
At close: Aug 10, 2026, 4:00 PM EDT
1.512
-0.088 (-5.52%)
After-hours: Aug 10, 2026, 5:39 PM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $1.65 million as of August 10, 2026. Its market cap has decreased by -62.72% in one year.
Market Cap
1.65M
Enterprise Value
-9.76M
1-Year Change
-62.72%
Ranking
Category
Stock Price
$1.60
ChartMarket Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $1.65M, a decrease of -98.39%. That is a compound annual growth rate of -42.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 1.65M | -13.53% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clearmind Medicine | 2.38M |
| Moleculin Biotech | 2.30M |
| Virax Biolabs Group | 2.30M |
| Azitra | 2.27M |
| Decoy Therapeutics | 2.04M |
| Genprex | 2.02M |
| Calidi Biotherapeutics | 1.98M |
| CDT Equity | 1.96M |